https://www.nasdaq.com/press-release/adial-pharmaceuticals-completes-private-placement-of-common-stock-at-%244.00-per-share
https://www.nasdaq.com/press-release/adial-announces-cary-j.-claiborne-a-renowned-pharmaceutical-executive-and-current
https://www.nasdaq.com/press-release/adial-pharmaceuticals-announces-positive-pre-clinical-data-for-pnv2-as-a-drug
https://www.nasdaq.com/press-release/reminder%3a-adial-pharmaceuticals-to-host-conference-call-thursday-november-18-2021-at
https://www.nasdaq.com/press-release/adial-pharmaceuticals-announces-private-placement-of-common-stock-at-%244.00-per-share
https://www.nasdaq.com/press-release/adial-pharmaceuticals-schedules-conference-call-to-provide-clinical-update-and-0
https://www.nasdaq.com/press-release/adial-appoints-renowned-pharmaceutical-executive-cary-j.-claiborne-to-board-of
https://www.nasdaq.com/press-release/adial-announces-positive-pre-clinical-data-for-purnovates-pnv-5030-as-drug-candidate
https://www.nasdaq.com/press-release/adial-pharmaceuticals-to-present-at-dawson-james-securities-6th-annual-small-cap
https://www.nasdaq.com/press-release/adial-pharmaceuticals-to-present-at-microcap-rodeos-fall-harvest-best-ideas-from-the
https://www.nasdaq.com/press-release/36-of-the-best-ideas-companies-to-present-at-the-fall-harvest-best-ideas-from-the-buy
https://www.nasdaq.com/press-release/adial-pharmaceuticals-announces-greater-than-50-of-patients-expected-to-complete
https://www.nasdaq.com/press-release/adial-pharmaceuticals-announces-research-collaboration-agreement-with-the-university
https://www.nasdaq.com/press-release/adial-ceo-william-stilley-invited-to-participate-in-maxim-groups-virtual-panel-series
https://www.nasdaq.com/press-release/adial-pharmaceuticals-to-present-at-the-h.c.-wainwright-23rd-annual-global-investment
https://www.nasdaq.com/press-release/adial-pharmaceuticals-exceeds-enrollment-target-in-onwardtm-phase-3-trial-of-ad04-for
https://www.nasdaq.com/press-release/adial-pharmaceuticals-reaches-full-enrollment-target-for-onwardtm-phase-3-trial-of
https://www.nasdaq.com/press-release/adial-pharmaceuticals-to-host-conference-call-today-at-11am-eastern-to-provide
https://www.nasdaq.com/press-release/adial-pharmaceuticals-to-host-conference-call-today-at-11am-eastern-to-provide
https://www.nasdaq.com/press-release/adial-pharmaceuticals-schedules-conference-call-to-provide-clinical-update-and
https://www.nasdaq.com/press-release/adial-pharmaceuticals-awarded-u.s.-and-international-patents-for-the-treatment-of
https://www.nasdaq.com/press-release/adial-pharmaceuticals-announces-closing-of-%245-million-private-placement-priced-at-a
https://www.nasdaq.com/press-release/adial-pharmaceuticals-reports-ceo-op-ed-featured-on-nasdaq.com-2021-07-29
https://www.nasdaq.com/press-release/adial-announces-positive-pre-clinical-data-for-its-adenosine-pain-platform-2021-07-14
https://www.nasdaq.com/press-release/adial-announces-%245000000-above-market-private-placement-at-%243.00-per-share-2021-07-07
https://www.nasdaq.com/press-release/the-phase-3-onwardtm-trial-meets-its-screening-target-and-nears-enrollment-completion
https://www.nasdaq.com/press-release/adial-joins-russell-microcapr-index-2021-06-28
https://www.nasdaq.com/press-release/adial-pharmaceuticals-provides-regulatory-and-development-update-2021-06-24
https://www.nasdaq.com/press-release/adial-pharmaceuticals-plans-to-enter-genetic-testing-market-following-allowance-of-u
https://www.nasdaq.com/press-release/adial-pharmaceuticals-comments-on-article-in-the-atlantic-highlighting-the-second
https://www.nasdaq.com/press-release/adial-announces-funding-of-management-led-%242100000-above-market-private-placement-at-
https://www.nasdaq.com/press-release/adial-pharmaceuticals-featured-on-multiple-news-broadcasts-nationwide-regarding-the
https://www.nasdaq.com/press-release/adial-pharmaceuticals-to-participate-at-the-benzinga-biotech-small-cap-conference-on
https://www.nasdaq.com/press-release/adial-founder-and-chief-medical-officer-dr.-bankole-johnson-featured-guest-on-the
https://www.nasdaq.com/press-release/adial-announces-management-led-%242100000-above-market-private-placement-at-%243.00-per
https://www.nasdaq.com/press-release/adial-schedules-town-hall-to-discuss-positive-updates-regarding-pharmaceutical
https://www.nasdaq.com/press-release/adial-receives-%241.425-million-in-net-proceeds-from-exercise-of-warrants-2021-02-26
https://www.nasdaq.com/press-release/adial-pharmaceuticals-achieves-50-enrollment-in-onwardtm-phase-3-trial-2021-02-25
https://www.nasdaq.com/press-release/adial-to-file-fast-track-application-for-ad04-with-the-fda-2021-02-23
https://www.nasdaq.com/press-release/adial-pharmaceuticals-closes-acquisition-of-purnovate-2021-01-26
https://www.nasdaq.com/press-release/adial-pharmaceuticals-to-present-at-23rd-annual-icr-conference-2021-01-11
https://www.nasdaq.com/press-release/adial-pharmaceuticals-receives-notice-of-allowance-for-third-u.s.-patent-covering
https://www.nasdaq.com/press-release/adial-pharmaceuticals-reaches-35-enrollment-in-onwardtm-pivotal-phase-3-trial-of-ad04
https://www.nasdaq.com/press-release/adial-pharmaceuticals-appoints-dr.-jack-reich-as-head-of-regulatory-2020-12-15
https://www.nasdaq.com/press-release/adial-pharmaceuticals-schedules-business-update-conference-call-to-discuss-planned
https://www.nasdaq.com/press-release/adial-pharmaceuticals-enters-agreement-to-acquire-purnovate-a-developer-of-potential
https://www.nasdaq.com/press-release/adial-pharmaceuticals-ceo-weighs-in-on-the-alcohol-pandemic-and-drunk-driving-over
https://www.nasdaq.com/press-release/adial-pharmaceuticals-lead-drug-candidate-ad04-for-treatment-of-alcohol-use-0
https://www.nasdaq.com/press-release/adial-pharmaceuticals-lead-drug-candidate-ad04-for-treatment-of-alcohol-use-disorder
https://www.nasdaq.com/press-release/adial-pharmaceuticals-enters-into-common-stock-purchase-agreement-with-keystone
https://www.nasdaq.com/press-release/adial-pharmaceuticals-provides-update-on-its-onwardtm-pivotal-phase-3-trial-of-ad04
https://www.nasdaq.com/press-release/todos-medical-announces-distribution-agreement-with-adial-pharmaceuticals-to-market-0
https://www.nasdaq.com/press-release/todos-medical-announces-distribution-agreement-with-adial-pharmaceuticals-to-market
https://www.nasdaq.com/press-release/avalon-globocare-and-adial-pharmaceuticals-announce-strategic-collaboration-for-0
https://www.nasdaq.com/press-release/avalon-globocare-and-adial-pharmaceuticals-announce-strategic-collaboration-for
https://www.nasdaq.com/press-release/adial-pharmaceuticals-announces-fda-reactivation-of-its-investigational-new-drug
https://www.nasdaq.com/press-release/adial-pharmaceuticals-announces-sale-of-10000-covid-19-antibody-rapid-test-devices
https://www.nasdaq.com/press-release/adial-pharmaceuticals-announces-covid-19-point-of-care-antibody-test-granted-first
https://www.nasdaq.com/press-release/adial-pharmaceuticals-files-for-expedited-review-of-ad04-with-the-fda-2020-09-25
https://www.nasdaq.com/press-release/adial-pharmaceuticals-and-iremedy-partner-to-sell-covid-19-antibody-test-kits-to-u.s.
https://www.nasdaq.com/press-release/adial-pharmaceuticals-to-present-at-the-h.c.-wainwright-22nd-annual-global-investment
https://www.nasdaq.com/press-release/adial-pharmaceuticals-to-present-at-the-ld-micro-500-virtual-conference-on-september
https://www.nasdaq.com/press-release/ld-micro-360-companies-set-to-present-this-week-2020-08-31
https://www.nasdaq.com/press-release/adial-pharmaceuticals-announces-third-party-sales-and-distribution-agreement-with
https://www.nasdaq.com/press-release/ld-micro-announces-preliminary-list-of-presenters-for-the-ld-500-2020-08-05
https://www.nasdaq.com/press-release/adial-pharmaceuticals-schedules-business-and-clinical-update-conference-call-2020-07
https://www.nasdaq.com/press-release/adial-pharmaceuticals-receives-european-medicines-agency-ema-agreement-on-the
https://www.nasdaq.com/press-release/adial-pharmaceuticals-announces-approval-to-commence-landmark-onwardtm-pivotal-0
